Moxifloxacinium chloride monohydrate

Acta Crystallographica Section E: Structure Reports Online

Volumn 67, Issue 10, 2011, Pages

  Qian, Jing Jing ^a   Gu, Jian Ming ^b   Shen, Jin ^a   Hu, Xiu Rong ^b   Wu, Su Xiang ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

data to parameter ratio = 14.3; mean (C C) = 0.005 ; R factor = 0.039; single crystal X ray study; T = 296 K; wR factor = 0.118

Indexed keywords

EID: 80054998853     PISSN: None     EISSN: 16005368     Source Type: Journal    
DOI: 10.1107/S160053681103707X     Document Type: Article

References (15)

1. Culley, C. M., Lacy, M. K., Klutman, N. & Edwards, B. (2001). Am. J. Health Syst. Pharm. 58, 379-388.
2. Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
3. Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.
4. Flack, H. D. (1983). Acta Cryst. A39, 876-881.
5. Higashi, T. (1995). ABSCOR. Rigaku Corporation, Tokyo, Japan.
6. Liu, H. & Sun, F. G. (2008). Adverse Drug React. J. 10, 141-142.
7. Noel, A. R., Bowker, K. E. & MacGowan, A. P. (2005). Antimicrob. Agents Chemother. 49, 4234-4239.
8. Ravikumar, K. & Sridhar, B. (2006). Acta Cryst. C62, o478-o482.
9. Rigaku (2006). PROCESS-AUTO. Rigaku Corporation, Tokyo, Japan.
10. Rigaku (2007). CrystalStructure. Rigaku, Tokyo, Japan.
11. Seidel, D., Conrad, M., Brehmer, P., Mohrs, K. & Petersen, U. (2000). J. Labelled Compd Radiopharm. 43, 795-805.
12. Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
13. Stass, H., Dalhoff, A., Kubitza, D. & Schuhly, U. (1998). Antimicrob. Agents Chemother. 42, 2060-2065.
14. Talib, S. H., Arshad, M., Chauhan, H., Jain, R. & Vaya, L. (2002). J. Indian Acad. Clin. Med. 3, 360-366.
15. Varanda, F., Pratas de Melo, M. J., Cac\,o, A. I., Dohrn, R., Makrydaki, F. A., Voutsas, E., Tassios, D. & Marrucho, I. M. (2006). Ind. Eng. Chem. Res. 45, 6368-6374.